💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Cytokinetics, Incorporated (CYTK)
« Back to company indexCYTK Chatter Timeline
Stock Ticker for CYTK
Most Active Tweeters for CYTK
| User | Tweets |
|---|---|
| @FlashAlert_me | 14 |
| @newsfilterio | 9 |
| @InsiderAlerts4U | 9 |
| @Tickeron | 7 |
| @Allstocknews | 6 |
Recent Tweets for CYTK
 |
@MichalFutera RT @Tickeron: $CYTK in Downtrend: Stochastic indicator peaks and leaves overbought zone. View odds for this and other indicators: https://t… April 14th 2021, 4:04pm |
 |
@Tickeron $CYTK in Downtrend: Stochastic indicator peaks and leaves overbought zone. View odds for this and other indicators:… https://t.co/TMQ8deHT77 April 14th 2021, 4:04pm |
|
@Tickeron $CYTK's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/TfSR7k01ck April 13th 2021, 11:04pm |
 |
@ShortAlgoKing $CYTK Waiting for buy signal. https://t.co/F815merqhD April 12th 2021, 11:04pm |
 |
@InsiderAlerts4U $CYTK: New Insider Filing on CYTOKINETICS INC's President & CEO ROBERT I BLUM: https://t.co/F4rWNm16lv April 12th 2021, 10:04pm |
 |
@FlashAlert_me $CYTK [15s. delayed] filed SEC form 4: President & CEO Blum Robert I: Disposed 5,000 of Common Stock at price $23.… https://t.co/vFxZNz5QFm April 12th 2021, 9:04pm |
 |
@formwhisperscom #FWSells $CYTK Blum Robert I, President & CEO of CYTOKINETICS INC sold 5,000 shares on 2021-04-12. https://t.co/b4wQP5QGEA April 12th 2021, 9:04pm |
 |
@fintel_io Insider Sandford D Smith reports selling 27,582 shares of $CYTK for a total cost of $659,990.00 https://t.co/3LXgMUt0iI April 12th 2021, 8:04pm |
|
@formwhisperscom #FWSells $CYTK SMITH SANDFORD D, Director of CYTOKINETICS INC sold 27,582 shares on 2021-04-09. https://t.co/b4wQP5QGEA April 12th 2021, 8:04pm |
 |
@TradeWithAlerts Large Print $CYTK Size: 230879 Price: 23.85 Time: 1600 Amount: $5,506,464.15 April 12th 2021, 8:04pm |
 |
@SmallCapsDaily $CYTK Cytokinetics Announces Preclinical Data for CK-3773274 Presented at the American Chemical Society Spring 2021… https://t.co/jUX8otSJgY April 12th 2021, 3:04pm |
 |
@Briefingcom $CYTK: Cytokinetics present data related to the optimization of CK-3773274 (CK-274), including the first disclosure… https://t.co/tSxteRHvHW April 12th 2021, 1:04pm |
 |
@IOInvestors $CYTK +1.6% (present data related to the optimization of CK-3773274 (CK-274), including the first disclosure of its… https://t.co/EtwimW9nAt April 12th 2021, 1:04pm |
|
@fintel_io $CYTK / Cytokinetics files form 8-K - Other Events - FORM 8-K https://t.co/FkoSuJz1PG April 12th 2021, 12:04pm |
|
@FlashAlert_me $CYTK [15s. delayed]: Issued Press Release on April 12, 07:30:00: Cytokinetics Announces Preclinical Data for CK-37… https://t.co/tE09jbUUiO April 12th 2021, 11:04am |
 |
@kevinjaybe $CYTK Cytokinetics Announces Preclinical Data For Ck-3773274 Presented At The American Chemical Society Spring 2021… https://t.co/Fq36K9SIXI April 12th 2021, 11:04am |
|
@FlashAlert_me $CYTK [15s. delayed] filed form 8-K on April 12, 07:30:23: Item8.01: Other Material Events https://t.co/Najyy5koYt April 12th 2021, 11:04am |
 |
@EdgarInsider Filing Alert, FORM 8-K [Press/News Current Report] available. $CYTK CYTOKINETICS INC https://t.co/j52JnTRSGM April 12th 2021, 11:04am |
 |
@Allstocknews $CYTK Cytokinetics Announces Preclinical Data for CK-3773274 Presented at the American Chemical Society Sprin From our Stock News Alerts App April 12th 2021, 11:04am |
 |
@stock_titan $CYTK Cytokinetics Announces Preclinical Data for CK-3773274 Presented at the American Chemical Society Spring 2021… https://t.co/AlXjX1JcEk April 12th 2021, 11:04am |
 |
@newsfilterio Form 4/A (statement of changes in beneficial ownership of securities) filed with the SEC $CYTK https://t.co/FQum6QeWJ5 April 10th 2021, 9:04am |
|
@Tickeron $CYTK in Downtrend: Stochastic indicator recovers from overbought zone. View odds for this and other indicators:… https://t.co/eXC9zr31KK April 10th 2021, 1:04am |
 |
@fda_tracker $CYTK Phase 2 trial w/est Apr completion date NCT04219826: https://t.co/OWFFDcJq5l Trial Tracker: https://t.co/aR7q5oJwjn April 9th 2021, 1:04pm |
|
@Tickeron $CYTK in Downtrend: Stochastic indicator leaves overbought zone. View odds for this and other indicators:… https://t.co/25wWOKoRim April 8th 2021, 10:04pm |
|
@InsiderAlerts4U $CYTK: New Insider Filing on CYTOKINETICS INC's Director JOHN T HENDERSON: https://t.co/YQfhmZAbVp April 8th 2021, 10:04pm |
 |
@mehabecapital Stocks in Insider Selling today: $CYTK, Current Price: $24.22, Change today: 3.64%, Total Traded Volume: 846783 https://t.co/CKfaFfjRMe April 8th 2021, 10:04pm |
|
@Allstocknews $CYTK New Form 4/A for Cytokinetics Inc From our Stock News Alerts App April 8th 2021, 10:04pm |
 |
@InsiderForms $CYTK Insider Malik Fady Ibraham has Sold 2,000 Shares. Title :EVP Research; Development Total Cost: $46,772.4 Buy/… https://t.co/gcdY9cFv4P April 8th 2021, 10:04pm |
|
@FlashAlert_me $CYTK [15s. delayed] filed SEC form 4/A: Director HENDERSON JOHN T: Delivered securities 2,684 of Common Stock at… https://t.co/EZzEQSii1t April 8th 2021, 10:04pm |
|
@fintel_io Insider Fady Ibraham Malik reports selling 2,000 shares of $CYTK for a total cost of $46,772.40 https://t.co/raHE4aqIEX April 8th 2021, 10:04pm |
|
@FlashAlert_me $CYTK [15s. delayed] filed SEC form 4: EVP Research & Development Malik Fady Ibraham: Disposed 2,000 of Common Sto… https://t.co/vUFd3Fpxju April 8th 2021, 10:04pm |
|
@formwhisperscom #FWSells $CYTK Malik Fady Ibraham, EVP Research & Development of CYTOKINETICS INC sold 2,000 shares on 2021-04-08. https://t.co/b4wQP5QGEA April 8th 2021, 10:04pm |
|
@TradeWithAlerts Large Print $CYTK Size: 104322 Price: 24.19 Time: 1600 Amount: $2,523,549.18 April 8th 2021, 8:04pm |
|
@Allstocknews $CYTK New Form DEF 14A for Cytokinetics Inc From our Stock News Alerts App April 7th 2021, 8:04pm |
|
@ShortAlgoKing $CYTK Strong short signal on the chart; waiting for buy signal. https://t.co/pIM7nuuTWc April 7th 2021, 2:04pm |
|
@InsiderAlerts4U $CYTK: New Insider Filing on CYTOKINETICS INC's Director SANDFORD D SMITH: https://t.co/mIecqarI2U April 7th 2021, 12:04pm |
 |
@1stOncology #Cytokinetics to Participate in the 20th Annual #NeedhamVirtualHealthcareConference $CYTK https://t.co/v0xfN3S6OQ April 7th 2021, 8:04am |
|
@InsiderAlerts4U $CYTK: New Insider Filing on CYTOKINETICS INC's EVP, Chief Commercial Officers ANDREW CALLOS: https://t.co/JLpigxPU6u April 6th 2021, 5:04pm |
 |
@MarcJacksonLA $CYTK Cytokinetics to Participate in the 20th Annual Needham Virtual Healthcare Conference | BioSpace https://t.co/8HK7RZS1TT #jobs April 6th 2021, 2:04pm |
|
@InsiderAlerts4U $CYTK: New Insider Filing on CYTOKINETICS INC's Director JOHN T HENDERSON: https://t.co/7G01nPAPny April 6th 2021, 12:04pm |
|
@newsfilterio $4,985.76 of shares acquired by Califf Robert (Director), reported in a new form 4 filed with the SEC $CYTK https://t.co/93bjLXrubM April 6th 2021, 8:04am |
|
@newsfilterio $18,745.48 of shares acquired by Gage L Patrick (Director), reported in a new form 4 filed with the SEC $CYTK https://t.co/FhVOHDVhgn April 6th 2021, 8:04am |
|
@newsfilterio $9,995.96 of shares acquired by Kaye Edward M. Md (Director), reported in a new form 4 filed with the SEC $CYTK https://t.co/NZ8LKezxAE April 6th 2021, 8:04am |
|
@newsfilterio $9,995.96 of shares acquired by Smith Sandford D (Director), reported in a new form 4 filed with the SEC $CYTK https://t.co/erAwdIt68c April 6th 2021, 8:04am |
|
@InsiderAlerts4U $CYTK: New Insider Filing on CYTOKINETICS INC's Director ROBERT CALIFF: https://t.co/R29OB1i9fw April 6th 2021, 8:04am |
|
@newsfilterio $9,995.96 of shares acquired by Wierenga Wendall (Director), reported in a new form 4 filed with the SEC $CYTK https://t.co/qYAhi5lZec April 6th 2021, 8:04am |
|
@newsfilterio $4,985.76 of shares acquired by Wysenski Nancy (Director), reported in a new form 4 filed with the SEC $CYTK https://t.co/LIp1btirYb April 6th 2021, 8:04am |
|
@InsiderAlerts4U $CYTK: New Insider Filing on CYTOKINETICS INC's Director WENDALL WIERENGA: https://t.co/Wowu3KPxkh April 6th 2021, 7:04am |
|
@newsfilterio $49,676.88 of shares sold by Henderson John T (Director), reported in a new form 4 filed with the SEC $CYTK https://t.co/TjqXuMJ8hr April 6th 2021, 7:04am |
|
@formwhisperscom #FWSells $CYTK HENDERSON JOHN T, Director of CYTOKINETICS INC sold 3,333 shares on 2021-04-01. https://t.co/b4wQP5QGEA April 6th 2021, 3:04am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
